Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Aptorum Group (NASDAQ: APM) has received a notification from Nasdaq Stock Market on April 15, 2025, regarding non-compliance with the minimum bid price requirement of $1 per share under Nasdaq Listing Rule 5550(a)(2).
The company has been granted a 180-calendar-day grace period until October 14, 2025, to regain compliance with the listing requirements. During this period, the trading of APM shares on Nasdaq will continue unaffected.
To address this situation, Aptorum Group is evaluating various options, including the possibility of implementing a reverse stock split. The biotechnology company has expressed its commitment to maintaining its Nasdaq listing and will pursue necessary measures to achieve compliance within the specified timeframe.
Aptorum Group (NASDAQ: APM) ha ricevuto una comunicazione dal Nasdaq Stock Market il 15 aprile 2025 riguardo al mancato rispetto del requisito minimo del prezzo di offerta di 1 dollaro per azione previsto dalla Regola di quotazione Nasdaq 5550(a)(2).
Alla societ脿 猫 stato concesso un periodo di grazia di 180 giorni di calendario fino al 14 ottobre 2025 per tornare a rispettare i requisiti di quotazione. Durante questo periodo, le azioni APM continueranno a essere negoziate sul Nasdaq senza interruzioni.
Per affrontare questa situazione, Aptorum Group sta valutando diverse opzioni, incluso il possibile ricorso a uno split azionario inverso. L'azienda biotecnologica ha ribadito il proprio impegno a mantenere la quotazione sul Nasdaq e adotter脿 le misure necessarie per raggiungere la conformit脿 entro i termini indicati.
Aptorum Group (NASDAQ: APM) recibi贸 una notificaci贸n del Nasdaq Stock Market el 15 de abril de 2025 sobre el incumplimiento del requisito m铆nimo de precio de oferta de 1 d贸lar por acci贸n, seg煤n la Norma de Listado Nasdaq 5550(a)(2).
La empresa ha recibido un per铆odo de gracia de 180 d铆as naturales hasta el 14 de octubre de 2025 para volver a cumplir con los requisitos de cotizaci贸n. Durante este tiempo, la negociaci贸n de las acciones de APM en Nasdaq continuar谩 sin interrupciones.
Para abordar esta situaci贸n, Aptorum Group est谩 evaluando varias opciones, incluida la posibilidad de implementar una consolidaci贸n inversa de acciones. La compa帽铆a biotecnol贸gica ha manifestado su compromiso de mantener su cotizaci贸n en Nasdaq y tomar谩 las medidas necesarias para cumplir con los requisitos dentro del plazo establecido.
Aptorum Group (NASDAQ: APM)電� 2025雲� 4鞗� 15鞚� 雮橃姢雼� 歃濌秾瓯半灅靻岆攵�韯� 欤茧嫻 斓滌唽 鞛呾鞍臧� 1雼煬 鞖旉贝鞚� 於╈”頃橃 氇豁枅雼る姅 韱奠毳� 氚涭晿鞀惦媹雼�. 鞚措姅 雮橃姢雼� 靸侅灔 攴滌箼 5550(a)(2)鞐� 霐半ジ 瓴冹瀰雼堧嫟.
須岇偓電� 靸侅灔 鞖旉贝鞚� 雼れ嫓 於╈”頃橁赴 鞙勴暣 2025雲� 10鞗� 14鞚缄箤歆� 180鞚缄皠鞚� 鞙犾槇 旮瓣皠鞚� 攵�鞐皼鞎橃姷雼堧嫟. 鞚� 旮瓣皠 霃欖晥 APM 欤检嫕鞚� 雮橃姢雼� 瓯半灅電� 鞓來枼鞚� 氚涭 鞎婈碃 瓿勳啀霅╇媹雼�.
鞚� 靸來櫓鞚� 頃搓舶頃橁赴 鞙勴暣 Aptorum Group鞚� 鞐硲頃� 欤检嫕 攵勴暊 鞁滍枆 臧�電レ劚鞚� 韽暔頃� 鞐煬 氚╈晥鞚� 瓴�韱� 欷戩瀰雼堧嫟. 鞚� 靸濍獏瓿淀暀 須岇偓電� 雮橃姢雼� 靸侅灔鞚� 鞙犾頃橁矤雼る姅 鞚橃毳� 響滊獏頄堨溂氅�, 歆�鞝曤悳 旮瓣皠 雮挫棎 攴滌爼 欷�靾橂ゼ 雼劚頃橁赴 鞙勴暅 頃勳殧頃� 臁办箻毳� 旆暊 瓴冹瀰雼堧嫟.
Aptorum Group (NASDAQ : APM) a re莽u une notification du Nasdaq Stock Market le 15 avril 2025 concernant la non-conformit茅 脿 l'exigence de prix d'offre minimum de 1 dollar par action selon la r猫gle de cotation Nasdaq 5550(a)(2).
La soci茅t茅 b茅n茅ficie d'une p茅riode de gr芒ce de 180 jours calendaires jusqu'au 14 octobre 2025 pour se conformer 脿 nouveau aux exigences de cotation. Pendant cette p茅riode, la n茅gociation des actions APM sur le Nasdaq se poursuivra sans interruption.
Pour rem茅dier 脿 cette situation, Aptorum Group 茅tudie plusieurs options, y compris la possibilit茅 de mettre en 艙uvre un regroupement d'actions invers茅. La soci茅t茅 de biotechnologie a r茅affirm茅 son engagement 脿 maintenir sa cotation au Nasdaq et prendra les mesures n茅cessaires pour respecter les exigences dans le d茅lai imparti.
Aptorum Group (NASDAQ: APM) erhielt am 15. April 2025 eine Mitteilung von der Nasdaq Stock Market 眉ber die Nichteinhaltung der Mindestgebotspreisanforderung von 1 US-Dollar pro Aktie gem盲脽 der Nasdaq-Listenregel 5550(a)(2).
Dem Unternehmen wurde eine kulante Frist von 180 Kalendertagen bis zum 14. Oktober 2025 einger盲umt, um die Anforderungen f眉r die Notierung wieder zu erf眉llen. W盲hrend dieses Zeitraums wird der Handel mit APM-Aktien an der Nasdaq unbeeintr盲chtigt fortgesetzt.
Um diese Situation zu bew盲ltigen, pr眉ft Aptorum Group verschiedene Optionen, einschlie脽lich der M枚glichkeit einer Aktienzusammenlegung. Das Biotechnologieunternehmen hat sein Engagement zur Aufrechterhaltung der Nasdaq-Notierung bekr盲ftigt und wird die notwendigen Ma脽nahmen ergreifen, um die Einhaltung innerhalb des festgelegten Zeitrahmens zu erreichen.
- 180-day grace period granted to regain compliance
- Trading continues unaffected during compliance period
- Stock price has fallen below $1, triggering Nasdaq minimum bid price compliance issues
- Potential reverse stock split may be necessary to maintain listing
- Risk of delisting from Nasdaq if compliance is not achieved by October 14, 2025
Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC dated 15 April 2025 regarding non-compliance with the minimum bid price requirement of
The notification does not immediately affect the listing or trading of the company鈥檚 shares on Nasdaq. Aptorum Group Limited has been granted a 180-calendar-day grace period, until 14 October 2025, to regain compliance with the continued listing requirements.
During this period, Aptorum Group Limited intends to evaluate all available options to restore compliance, including, if necessary, a reverse stock split. The company is committed to maintaining its Nasdaq listing and will take all reasonable measures to achieve compliance within the stipulated time frame.
About Aptorum Group Limited
Aptorum Group Limited is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs.
Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect the company鈥檚 current expectations and projections about future events and are based on assumptions. Actual results may differ materially from those projected.
For further information, please contact:聽
FAQ
What is the deadline for Aptorum Group (APM) to regain Nasdaq compliance?
What is the minimum share price requirement that APM needs to meet for Nasdaq compliance?
Will APM stock continue trading on Nasdaq during the compliance period?
What solutions is Aptorum Group (APM) considering to address the Nasdaq compliance issue?
